About

This website and these videos was produced by the independent medical educations- and publishing company Mediahuset i Göteborg AB from Sweden. Mediahuset has more than three decades of experience from producing educational content in all forms for health care professionals from all over the world.

Would you like to know more about Mediahuset? Feel free to contact us at info@mediahuset.se or visit our (Swedish) website www.mediahuset.se.

Sponsorship

These educational videos are sponsored by Gilead Sciences and intended only for healthcare providers. Gilead does not recommend the use of any product in any different manner than as described in the Local Prescribing Information. All opinions represented in this lecture are entirely the speaker’s views and do not necessarily represent Gilead

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable Adverse reactions may also be reported directly to the manufacturer of the suspected product. Adverse reactions related to Gilead products may be reported directly to Gilead via Drugsafety.dubai@gilead.com

If you have any questions related to Gilead products please send them to: askgileadME@gilead.com

Content

For this particular event, Mediahuset contracted the speakers with the assignment to summarize the most important updates from EULAR in their own perspective. The content of these videos are therefor solely the speakers own opinions and/or impressions. Not Mediahuset, nor Gilead, has been able to influence the content.